KRAS-mutant Colon Cancer Cells Respond to Combined Treatment of ABT263 and Axitinib

Bioscience Reports - Netherlands
doi 10.1042/bsr20181786
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

Combined MEK and BCL-XL Inhibition Kills KRAS -Mutant Cells

Cancer Discovery
Oncology
2012English

New Strategies for Treatment of KRAS Mutant Metastatic Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2010English

Cancer-Associated Fibroblasts Do Not Respond to Combined Irradiation and Kinase Inhibitor Treatment

Oncology Reports
MedicineCancer ResearchOncology
2012English

Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 Kinase in KRAS -Mutant Lung Cancer

Cancer Discovery
Oncology
2013English

Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models

Cancer Cell
Cancer ResearchOncologyCell Biology
2013English

MEK Nuclear Localization Promotes YAP Stability via Sequestering Β-TrCP in KRAS Mutant Cancer Cells

Cell Death and Differentiation
Cell BiologyMolecular Biology
2019English

Targeted Photodynamic Therapy as Potential Treatment Modality for the Eradication of Colon Cancer and Colon Cancer Stem Cells

Tumor Biology
MedicineCancer Research
2017English

Impact of Mutant Β-Catenin on ABCB1 Expression and Therapy Response in Colon Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2012English

Targeting Oncogenic Protein Kinase Cι for Treatment of Mutant KRAS LADC

Small GTPases
BiochemistryCell Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy